APA

Sharma A., Mani S., Hanna N., Guha C., Vikram B., Weichselbaum R. R., Sparano J., Sood B., Lee D., Regine W., Muhodin M., Valentino J., Herman J., Desimone P., Arnold S., Carrico J., Rockich A. K., Warner-Carpenter J. & Barton-Baxter M. (20010809). Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors. : Human gene therapy.

Chicago

Sharma A, Mani S, Hanna N, Guha C, Vikram B, Weichselbaum R R, Sparano J, Sood B, Lee D, Regine W, Muhodin M, Valentino J, Herman J, Desimone P, Arnold S, Carrico J, Rockich A K, Warner-Carpenter J and Barton-Baxter M. 20010809. Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors. : Human gene therapy.

Harvard

Sharma A., Mani S., Hanna N., Guha C., Vikram B., Weichselbaum R. R., Sparano J., Sood B., Lee D., Regine W., Muhodin M., Valentino J., Herman J., Desimone P., Arnold S., Carrico J., Rockich A. K., Warner-Carpenter J. and Barton-Baxter M. (20010809). Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors. : Human gene therapy.

MLA

Sharma A, Mani S, Hanna N, Guha C, Vikram B, Weichselbaum R R, Sparano J, Sood B, Lee D, Regine W, Muhodin M, Valentino J, Herman J, Desimone P, Arnold S, Carrico J, Rockich A K, Warner-Carpenter J and Barton-Baxter M. Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors. : Human gene therapy. 20010809.